12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several healthcare stocks experienced significant movements. Adial Pharmaceuticals (ADIL) saw a 30.5% increase in shares to $2.78, while Dyadic International (DYAI) rose by 9.35% to $1.87. AcelRx Pharmaceuticals (ACRX) shares went up by 9.34% to $0.75, Quoin Pharmaceuticals (QNRX) increased by 9.33% to $4.8, and Revelation Biosciences (REVB) rose by 9.2% to $0.8. NexImmune (NEXI) also saw a rise of 9.03% to $1.81. On the losing side, China Pharma Holding (CPHI) shares fell by 10.6% to $0.12, Vivos Therapeutics (VVOS) declined by 9.76% to $37.0, Altamira Therapeutics (CYTO) dropped by 8.23% to $0.59, Kintara Therapeutics (KTRA) decreased by 6.33% to $0.37, Addex Therapeutics (ADXN) fell by 6.2% to $5.3 following their Q3 earnings report, and LumiraDx (LMDX) went down by 5.88% to $0.11.
November 29, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AcelRx Pharmaceuticals shares rose by 9.34% to $0.75, with a market cap of $12.6 million.
ACRX's share price increase may lead to a short-term positive trend, driven by after-market trading activity.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Adial Pharmaceuticals shares surged 30.5% to $2.78, with a market cap of $3.3 million.
The significant after-market gain for ADIL indicates positive investor sentiment which could lead to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Dyadic International shares increased by 9.35% to $1.87, with a market cap of $53.8 million.
The after-market rise in DYAI's stock price suggests a positive short-term outlook, potentially due to investor confidence.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
NexImmune shares increased by 9.03% to $1.81, with a market cap of $1.9 million.
The rise in NEXI's shares suggests a potential short-term bullish trend, influenced by after-market activity.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Quoin Pharmaceuticals stock moved upwards by 9.33% to $4.8, with a market cap of $4.7 million.
The increase in QNRX's stock price could suggest a short-term upward momentum due to investor trading in the after-market session.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Revelation Biosciences stock increased by 9.2% to $0.8, with a market cap of $5.0 million.
REVB's after-market stock price rise may indicate a short-term positive trend, possibly due to investor optimism.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Addex Therapeutics shares fell 6.2% to $5.3 following their Q3 earnings report, with a market cap of $4.3 million.
The post-earnings drop in ADXN's share price likely reflects a negative investor response to the Q3 earnings report, suggesting a bearish short-term impact.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
China Pharma Holding shares fell by 10.6% to $0.12, with a market cap of $3.7 million.
The significant drop in CPHI's stock price could lead to a negative short-term impact, reflecting bearish investor sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Altamira Therapeutics shares fell 8.23% to $0.59, with a market cap of $4.7 million.
The decrease in CYTO's stock price indicates a potential short-term downward trend, likely due to negative market sentiment.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Kintara Therapeutics stock decreased by 6.33% to $0.37.
KTRA's after-market drop could be indicative of a short-term negative price direction, potentially due to investor selling.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
LumiraDx stock fell 5.88% to $0.11, with a market cap of $35.2 million.
LMDX's decline in the after-market session may signal a short-term negative trend, possibly due to broader market concerns.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Vivos Therapeutics stock declined by 9.76% to $37.0, with a market cap of $44.2 million.
VVOS's after-market decline may suggest a short-term negative price movement, possibly due to investor reactions to market conditions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100